Navigation Links
Micromet Appoints Former Roche Oncology Clinical Leader Jan Fagerberg as Chief Medical Officer
Date:9/22/2009

BETHESDA, Md., Sept. 22 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the appointment of Jan Fagerberg, M.D., Ph.D., as Senior Vice President and Chief Medical Officer effective November 1, 2009.

Dr. Fagerberg is a board-certified clinical oncologist and has more than 20 years of experience in clinical research and development of oncology drugs. His experience includes several years at F. Hoffmann-La Roche in positions of increasing responsibility both in the US and in Switzerland, ultimately serving as the Therapeutic Area Expert Oncology in Global Drug Development of Hoffmann-La Roche in Basel, Switzerland. During his tenure at Roche, he was responsible for the global clinical development of Xeloda, and for the clinical development programs of Avastin outside the US. He was also advising Roche's clinical development teams globally on the development of all compounds for the treatment of gastrointestinal cancers. Dr. Fagerberg has extensive US and European regulatory experience, and was successful in obtaining 11 FDA and EMEA approvals for Xeloda and Avastin. Dr. Fagerberg joins Micromet from TopoTarget where he was Medical Director responsible for the pivotal clinical development program for belinostat for the treatment of peripheral T-cell lymphoma.

"We are very pleased to have Jan Fagerberg join us as our new Chief Medical Officer," said Christian Itin, Micromet's Chief Executive Officer. "Jan's extensive clinical and regulatory experience will be a tremendous asset as we are preparing pivotal stage clinical trials for blinatumomab."

"I am excited about the opportunity to advance the development of bli
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors
2. Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO/ESMO on September 22, 2009
3. Micromet to Present at the UBS Global Life Sciences Conference on September 22, 2009
4. Micromet to Present at the 16th Annual NewsMakers in the Biotech Industry Conference on September 16, 2009
5. Micromet Closes $80.5 Million Public Offering of Common Stock
6. Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab
7. Micromet Announces Pricing of Public Offering of Common Stock
8. Micromet Announces Public Offering of Common Stock
9. Micromet, Inc. to Host Conference Call and Webcast to Report Second Quarter 2009 Financial Results on August 6, 2009
10. Micromet Added to Russell 3000 Index
11. Micromet to Host Conference Call and Webcast to Discuss Blinatumomab Data Presented at EHA on June 8, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014 WABC Radio show out of New ... Lorry Young will be hosting California-based Vet-Stem, Inc.’s Founder and ... therapy in pets. Dr. Harman first visited the show ... therapy for pets suffering from osteoarthritis and other degenerative diseases, ... industry forward. , Young has invited Dr. Harman back to ...
(Date:7/25/2014)... 2014 Lawrence Livermore scientists Charles Westbrook ... list of " The World's Most Influential Scientific Minds ... 3,000 researchers who were identified by analyzing citation data ... published the highest-impact work (2002-2012 and 2012-2013). The two ... combustion modeling . , "This recognition is a great ...
(Date:7/25/2014)... July 25, 2014 /PRNewswire-iReach/ -- Xybion Corporation, the ... global corporations operating in highly regulated industries, announced ... annual Global User Group Conference, Xybion International Exchange, ... Philadelphia, Pennsylvania at the Sheraton Society ... This year,s conference theme ...
(Date:7/25/2014)... -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a ... , today announced that it will release its unaudited financial ... market close on Thursday, August 14, 2014 EDT. The Company ... on Friday, August 15, 2014, at 8:00 a.m. EDT (Friday, ... review the Company,s financial results and provide an update on ...
Breaking Biology Technology:Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode of A “Paws” For Your Pet 2Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode of A “Paws” For Your Pet 3Scientists Burst onto Influential List for Combustion Research 2Scientists Burst onto Influential List for Combustion Research 3Scientists Burst onto Influential List for Combustion Research 4Xybion Announces It Will Host International User Conference in Philadelphia 2Xybion Announces It Will Host International User Conference in Philadelphia 3Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results 2
... Valencia (UV) has confirmed that the substance used to hermetically ... was pine resin. The scientists also studied the metallic fragments ... used for iron-working. In 2005, a group of archaeologists ... at Lixus, an ancient settlement founded by the Phoenicians near ...
... CRANBURY, N.J. , Feb. 5 Amicus Therapeutics ... has elected John F. Crowley as Chairman of the ... (CEO), effective immediately.  Mr. Crowley will succeed Donald J. Hayden, ... Board. , "The Board,s decision to elect Mr. Crowley as Chairman ...
... Stuart Lindsay, Arizona State University Regents, professor and director ... has just released the first comprehensive guide to a ... grain of sand. Introduction to Nanoscience (published by ... an emerging discipline which has in recent years, produced ...
Cached Biology Technology:Chemical analyses uncover secrets of an ancient amphora 2Amicus Therapeutics Board of Directors Names Chief Executive Officer John F. Crowley Chairman of the Board 2Big book explores a small world: Stuart Lindsay's guide to nanoscience 2Big book explores a small world: Stuart Lindsay's guide to nanoscience 3
(Date:7/24/2014)... Scientists at The New York Stem Cell ... to creating a viable cell replacement therapy for ... , For the first time, NYSCF scientists generated ... samples of patients with primary progressive multiple sclerosis ... induce these stem cells into becoming oligodendrocytes, the ...
(Date:7/24/2014)... 2014) Scientists at The New York Stem ... closer to creating a viable cell replacement therapy ... , For the first time, NYSCF scientists ... skin samples of patients with primary progressive multiple ... to induce these stem cells into becoming oligodendrocytes, ...
(Date:7/24/2014)... factors that characterize sustainable university and college programs ... physics teachers. Specifically, one or more faculty members ... combination with institutional motivation and commitment can ensure ... and Math (STEM) teacher shortages are especially acute ... for institutions seeking to increase the number of ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Creating sustainable STEM teacher preparation programs 2
... his research team at the Centre for Stem Cell Research ... ( http://dev.biologists.org/ ) a new and safer way of ... give rise to every tissue of the body. Rapid developments ... way for stem cell scientists to convert specialised cells, such ...
... Just the mention of this iconic spring and early ... drinks and sweet desserts. Researchers interested in learning more ... of strawberries, a strong influence on consumer preferences, is ... texture, and appearance. The goals of a recent ...
... most often as a healthy, convenient food, are also ... plants are highly prized by many as one of ... ambiance in gardens and pool environments. A research ... journal HortTechnology detailed a study of 33 ...
Cached Biology News:Researchers piggyback to safer reprogrammed stem cells 2Analysis of fresh strawberries reveals consumer preferences 2